Novonesis A/S Class B
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Ester Baiget
- Full Time Employees
- 11,641
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Biologiens Vej 2 Lyngby ND Denmark 2800
- IPO Date
- May 27, 1905
- Website
- novonesis.com
- Similar Companies
- Business
- Novonesis A/S (formerly Novozymes A/S) develops and produces industrial enzymes, microorganisms, biopharmaceutical ingredients, and biosolutions for multiple sectors including agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile, and wastewater treatment; core offerings encompass lipases, proteases, oxidoreductases, carbohydrases, and specialized enzymes for dairy, baking, beverages, meat, plant-based foods, and functional nutrition, alongside probiotics, biopolymers, and proteins serving over 40 industries globally. Founded in 2000 as a spin-off from Novo Nordisk with roots tracing to 1925, the company is headquartered in Bagsværd, Denmark, and maintains production and R&D facilities across more than 140 countries, including the United States, China, Brazil, India, and the United Kingdom. In January 2024, Novozymes merged with Chr. Hansen in a statutory combination approved by regulators to form Novonesis, creating a global biosolutions leader with projected 6-8% organic sales growth through 2025, EUR 200 million in revenue synergies, and enhanced capabilities in biological innovation for sustainable applications.
Company News
Novozymes A/S (OTCMKTS:NVZMF) Share Price Crosses Above Fifty Day Moving Average – What’s Next?
Financial Analysis: Novozymes A/S (OTCMKTS:NVZMY) vs. Neo Performance Materials (OTCMKTS:NOPMF)
FUL or NVZMY: Which Is the Better Value Stock Right Now?
Novozymes A/S (NVZMY) Q2 2026 Earnings Call Transcript
FUL vs. NVZMY: Which Stock Is the Better Value Option?
FUL or NVZMY: Which Is the Better Value Stock Right Now?
FUL or NVZMY: Which Is the Better Value Stock Right Now?
FUL vs. NVZMY: Which Stock Should Value Investors Buy Now?
FUL or NVZMY: Which Is the Better Value Stock Right Now?
Analyzing Novozymes A/S (OTCMKTS:NVZMY) & Orion (NYSE:OEC)
Novozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript
Novozymes A/S (OTCMKTS:NVZMF) Share Price Crosses Below Fifty Day Moving Average – Here’s What Happened
NVZMY vs. HWKN: Which Stock Is the Better Value Option?
Novozymes A/S (OTCMKTS:NVZMY) Short Interest Update
KROS or NVZMY: Which Is the Better Value Stock Right Now?
Novozymes A/S (NVZMY) Q3 2025 Earnings Call Transcript
KMDA vs. NVZMY: Which Stock Is the Better Value Option?
Novonesis A/S (NVZMF) Q2 2025 Earnings Call Transcript
Novozymes (NVZMY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Novonesis: Industry Leader With Defensive Characteristics And Solid Growth